This ones a heck of a specualive investment but it seems that the institutions are willing to stomp up the cash to back it in the long term.

Heres the latest news from Killik stocbrokers on the company..........

MEDICAL MARKETING Joint Venture

We recently highlighted Medical Marketing (MMG) as worthy of attention. The company, in which I have a personal share holding, has this morning announced the formation of a joint venture, Genvax, to develop a novel DNA vaccine platform technology.

Human trials have been underway since 2001 in areas such as Lymphoma and Myeloma but the technology has broad applications in cancer, viral and bacterial infections (hence the term platform). The technology works on boosting the immune system by teaching it to identify hard to recognise cancer proteins as foreign and destroy them. Early results from the 25 patient trial in lymphoma are encouraging and evaluation of the result is expected by March 2005. Successful results should mean big pharmaceutical groups will start to take financial and commercial interests around that time.

This looks to be the first of a series of announcements due from Medical Marketing as it has a range of predominantly cancer trials moving into the clinical stage. (news flow could push the price higher)

The stock has made good progress in recent sessions up to the mid-80p level where the company is valued at just under 40 million. ENDS.

Please DYOR

cheers GF.

Thanks GF. Here's another one for you.

Optimist at large - 13 Mar'06 - 08:49 - 7036 of 7043


From the BBC this morning:

Vaccines 'may block many cancers'

Vaccines could combat viruses that trigger cancer
Anti-viral vaccines have the potential to prevent one in ten cases of cancer in Britain, and as many as 25% in the developing world, a report says.
The Cancer Research UK study estimates there are more than 1.8 million new cases of virus-associated cancer world-wide each year.

The charity says just a handful of viruses are to blame.

It says greater investment in new vaccines could be a highly productive way to combat cancer.

Cancers linked to infection with particular viruses include:


Cervix
Stomach
Liver
Nasopharyngeal carcinoma (nasal passages)
Lymphomas
Leukaemia
The report stresses that only a small proportion of people infected with viruses linked to cancer go on to develop the disease.

As today we successfully vaccinate against infectious diseases so we shall soon be able to vaccinate against certain types of cancer

Professor John Toy

However, it estimates that as many as 18% of new cases of cancer each year are linked to viral infections.

Lead researcher Professor Alan Rickinson, from the University of Birmingham, said: "Studying the association between infectious agents and human cancers is extremely important because, in such cases, infection represents one defined link in the chain of events leading to cancer development.

"Knowing this helps us to trace other links in the chain and to understand how the whole chain fits together.

"More importantly, if we can break the chain by preventing the infection through vaccination, then we can prevent the cancer developing."

Vaccine development is most well advanced in the case of cervical cancer, which is largely caused by infection with the human papilloma virus (HPV).

Rival products

Rival drug companies are battling to bring products to market, with the expectation that they could prevent around 70% of all cases of the disease.

However, Dr Anne Szarewski, clinical consultant at Cancer Research UK, said there was still work to be done.

"We don't know yet how long immunity will last, and if booster vaccines will be required.

"The longest period for which women have been followed up after an HPV vaccine trial has been four years."

A vaccine has also been developed for the Hepatitis B virus which is linked to liver cancer.

No vaccines have yet been developed to help combat stomach cancer, nasopharyngeal carcinoma and the lymphomas and leukaemias associated with infections.

Professor John Toy, medical director of Cancer Research UK, said it was important people understood it was not possible to "catch" cancer, in the same way as a cold or flu virus.

But he added: "As today we successfully vaccinate against infectious diseases so we shall soon be able to vaccinate against certain types of cancer."

From the BBC aswell, Excelent. Only time now. As Evil got out yet???????????

cheers GF.

No not yet GF. He's got to be monitoring the situation. I don't know at what price he opened his short so can't tell if he is up or down. I have to say this is one stock I would not want to be short of, even if, at this moment in time it's still a bit " blue sky". With this, it can change at a moments notice, as we all remember last year when it went against us.

LOL
MS

I dont think hes very much in profit mickey.

Anyway a week off for me tomorrow watching the racing from Cheltnam aslong as weather is ok, if not in the local all week, 24/24, oh bliss........... on the piss.........

will not miss ............... her indoors.

cheers GF.

I thought his entry point was around the 250p mark.

He went in a few times dont forget though Pete.

cheers GF.

Hello GF and Mickey things really are looking good today ,buys starting to go through at 1.91.
I thought investor sentiment might be hurt today given the news about six men being taken seriously ill during clinical trials run by Parexel for a drug to treat chronic inflammatory conditions and leukaemia.

Yes I heard about that. Just goes to show how cutting edge these drugs are, though nothing to do with us. Let's hope we get some news soon.

MS

Its been a while since we were at these levels,lets hope there is a lot more to come.

The spreadbet co's seem fully stocked which indicates little or no news could trigger the freefall we had this time last year as the tight stop losses get hit one after the other all the way down to the 110-130 levels.

Me, well I'm hopeful that 1 year on from the Lymphoma trial, we will have news that the immune response has been improved even further by a bit more tweaking.
Also keen to get a bit more detail on the prostate cancer trial which has a reported endpoint of Feb/Mar 2006(I think).
Not sure if we'll hear anything on the flu vaccines as Dr Ottensmeier has been billed as talking about cancer vaccine trials.

Was there a presentation today? If so anyone heard any news.

MS

From the other place.

el magnifico - 15 Mar'06 - 15:39 - 7074 of 7074


I recall that MMI issued its "MMI announces cancer vaccines update" RNS on 22nd March 2005, following Dr Stevenson's presentation at DNA Vaccines Forum on 18th March 2005.

So I would not be disappointed by the absence of an RNS tomorrow, although I have a feeling that Cancer Research UK / Leukaemia Research Foundation may be building up to a biggie on GenVax soon.

We are one year further down the trials path and the MMI share price is unchanged. Risk / reward extremely favourable.

IMHO the price action, now squeezing above the September 2005 1.85 top, together with the stealthy accumulation volume characteristics suggest that you won't be able to get 'em much cheaper than this.

el

DNA Vaccines Forum 16th and 17th March

Presentation 16.20 p.m

Freda Stevenson Professor of Immunology (Tenovus Laboratory University of Southampton)

Advancements In Cancer Research.

1) Therapeutic applications of DNA Fusion Vaccines


2) Focus on design and delivery

3)Clinical testing in human patients.

Maybe some good news Friday or early next week
Fingers crossed.

Looking good to me.

MS

After checking todays RNS I have topped up. Looking very good indeed, especialy David Bests comments if you read between the lines.

More good news in the RNS today.

cheers GF.

Just got in and have seen the good news,it came a bit sooner than i expected .

EK has got to get out now surely!

He's a stubborn old fox DB but if he does I'll let you know.

MS

Why are people starting to sell? I am very nervous after last year and don't want to see my profits eroded.

They soon moved the price down on what is not the greatest sell volume,i just hope they bloody well move it up as quick as they moved it down.